Who Paid My Doc Search
Menu
Organisation paid for research Program year 2025 Source: CMS Open Payments

The Retina Partners

Neither a doctor nor a teaching hospital

Research payments

$5,549,474

850 payments

Through program year 2025, The Retina Partners is reported as receiving $5,549,474 in research payments, across 850 payments.

By program year

7 rows
Year Kind Amount Payments
2025 Research $923,903 550
2024 Research $315,292 45
2023 Research $936,304 79
2022 Research $563,280 30
2021 Research $1,379,113 70
2020 Research $952,136 44
2019 Research $479,447 32

Breakdown

Who paid Research payments · program years 2019–2025
  1. Genentech, Inc. $3,685,895 249 payments
  2. Regeneron Pharmaceuticals, Inc. $719,992 455 payments
  3. Hexal AG $232,496 14 payments
  4. Apellis Pharmaceuticals, Inc. $205,993 15 payments
  5. Ocular Therapeutix, Inc. $180,657 45 payments
  6. Kyowa Kirin, Inc. $166,939 48 payments
  7. EyePoint Pharmaceuticals US, Inc. $163,735 2 payments
  8. Alexion Pharmaceuticals, Inc. $115,632 5 payments
  9. AbbVie, Inc. $38,116 5 payments
  10. Allergan Inc. $22,577 6 payments
Studies the money was for Research payments · program years 2019–2025
  1. Va2 Phiii $545,442 12 payments
  2. A Randomized, Double-Masked, Active-Controlled Phase 2/3 Study of the Efficacy and Safety of High-Dose Aflibercept in Patients With Diabetic Macular Edema $542,917 366 payments
  3. Study of the Port Delivery System With Ranibizumab in Patients With Diabetic MacUlar Edema $451,878 20 payments
  4. Va2 Phiii Rhine $346,613 14 payments
  5. Port Delivery System for Ranibizumab $304,933 18 payments
  6. Ah and Imaging Biomarker Study $289,376 5 payments
  7. Port Delivery System of Ranibizumab Extension Study $283,330 19 payments
  8. Phase 2 of Ro7171009 in Ga $239,439 17 payments
  9. Csok583a12301 $232,496 14 payments
  10. Port Delivery System of Ranizibumab Extension Study $206,337 10 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record